ACOPP chemotherapy for front-line treatment of older patients with Hodgkin lymphoma - a pilot study

被引：0

作者：

Wilson, M. ^{[1
]}

Mckay, P. ^{[1
]}

Parsons, K. ^{[1
]}

Ogilvie, C. ^{[1
]}

Travers, J. ^{[1
]}

Martin, M. ^{[1
]}

Allan, J. ^{[1
]}

Osborne, W. ^{[2
]}

Leach, M. ^{[1
]}

机构：

[1] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland

[2] Newcastle Upon Tyne NHS Trust, Newcastle, NSW, Australia

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BSH2020-EP

引用

页码：227 / 227

页数：1

共 50 条

[41] Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
Maurillo, Luca
Buccisano, Francesco
Spagnoli, Alessandra
Voso, Maria Teresa
Fianchi, Luana
Papayannidis, Cristina
Gaidano, Gian Luca
Breccia, Massimo
Musto, Pellegrino
De Bellis, Eleonora
Del Principe, Maria Ilaria
Lunghi, Monia
Lessi, Federica
Martinelli, Giovanni
Venditti, Adriano
ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1767 - 1774
[42] PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE (SER) TO FRONT-LINE CHEMOTHERAPY (KEYNOTE-667)
Vinti, Luciana
Daw, Stephen
Alvarez, Constantino Sabado
Fagioli, Franca
Beishuizen, Auke
Michel, Gerald
Moleti, Maria
Cepelova, Michaela
Thorwarth, Anne
Rigaud, Charlotte
De Sabando, Diego Plaza Lopez
Landman-Parker, Judith
Shen, Juan
Pillai, Pallavi
Marinello, Patricia
Mauz-Koerholz, Christine
PEDIATRIC BLOOD & CANCER, 2023, 70 : S29 - S30
[43] BACOP/FR combination chemotherapy as front-line treatment of follicular lymphoma. A phase II study of the Gruppo Italiano Studio Linfomi (GISL).
Luminari, S.
Lombardo, M.
Mammi, C.
Bellei, M.
Merli, F.
Stelitano, C.
Lazzaro, A.
Marasca, R.
Brugiatelli, M.
Federico, M.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 439S - 439S
[44] Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma
Prince, HM
Crump, M
Imrie, K
Stewart, AK
Girouard, C
Brandwein, JM
Carstairs, K
Pantalony, D
Scott, G
Sutcliffe, S
Sutton, DMC
Tsang, R
Keating, A
ANNALS OF ONCOLOGY, 1996, 7 (10) : 1043 - 1049
[45] Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site
Pouessel, D
Culine, S
Becht, C
Ychou, M
Romieu, G
Fabbro, M
Cupissol, D
Pinguet, F
CANCER, 2004, 100 (06) : 1257 - 1261
[46] Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site
Muñoz, A
Barceló, JR
López-Vivanco, G
CANCER, 2004, 101 (03) : 653 - 654
[47] Phase II study of low-dose decitabine for the front-line treatment of older patients with acute myeloid leukemia (AML).
Cashen, Amanda
Schiller, Gary J.
Larsen, Julie S.
Cullen, Michael T., Jr.
DiPersio, John F.
BLOOD, 2006, 108 (11) : 561A - 562A
[48] A phase II study of pernetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelimma (MPM).
Ceresoli, GL
Zucali, PA
Favaretto, A
Marangolo, M
Del Conte, G
Grossi, F
Ceribelli, A
Bidoli, P
Bearz, A
Santoro, A
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 663S - 663S
[49] CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas: A pilot study.
Jeon, SB
Kim, JG
Baek, JH
Kim, DH
Sohn, SK
Lee, JJ
Chung, IJ
Kim, HJ
Lee, WS
Sohn, CH
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 594S - 594S
[50] A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)
Parra, HS
Zucali, R
Favaretto, A
Grossi, F
Fusi, A
Marangolo, M
Del Conte, G
Ceribelli, A
Bearz, A
Ceresoli, G
LUNG CANCER, 2005, 49 : S229 - S229

← 1 2 3 4 5 →